IP Library › Granted Patent US 12,721,980
Granted Patent B2
US 12,721,980 · App. 17/235,615 · Granted Sep 1, 2026

Devices and systems for access and navigation of cerebrospinal fluid space

Inventor: Abhi Vase (Los Altos Hills, CA)
A61M27/006A61B17/221A61M25/0026A61M25/003A61M25/0043A61M25/0053A61M25/0068A61M25/007A61M25/0097A61B5/00A61B17/12A61B2017/22034A61B2017/22051A61B2017/2215A61B2090/064A61M2025/0002A61M2025/0031A61M25/0032A61M25/0041A61M2025/0042A61M25/0045A61M2025/0059A61M25/0067A61M2025/0681A61M25/1011A61M2025/1079A61M2205/3331A61M2210/0693
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,721,980
App. No.
17/235,615
Granted
Sep 1, 2026
Kind
B2
Abstract

The present disclosure relates to accessing, removing, exchanging and recirculating cerebrospinal fluid (CSF). Devices, systems and methods disclosed herein are used to safely and efficiently navigate the space at and around the brain and spinal cord where the CSF flows through the body, also known as the CSF space.

Claims (25)

1 . A catheter comprising:

a proximal subassembly defining two proximal lumens, a proximal subassembly coil having a first pitch, and a plurality of first openings each extending through a wall of the proximal subassembly and disposed between adjacent coil windings of the proximal subassembly coil;

a distal subassembly defining a single distal lumen, a distal subassembly coil having a second pitch which is larger than the first pitch, and a plurality of second openings each extending through a wall of the distal subassembly and disposed between adjacent coil windings of the distal subassembly coil, wherein the plurality of second openings are arranged only in an alternating fashion on a top and a bottom portion of the catheter and each have a two coil pitch spacing;

wherein the proximal subassembly coil and the distal subassembly coil are separate and discontinuous with one another; and

wherein the distal subassembly coil is embedded in the wall of the distal subassembly.

2 . The catheter of claim 1 , wherein the proximal subassembly includes an inner wall and an outer wall.

3 . The catheter of claim 2 , wherein the two proximal lumens include a first lumen and a second lumen, and the first lumen is defined by the inner wall, and the second lumen is defined by a space between the inner wall and the outer wall.

4 . The catheter of claim 3 , wherein the plurality of first openings each extend through the outer wall of the proximal subassembly and are in fluid communication with the second lumen.

5 . The catheter of claim 1 , wherein the wall of the distal subassembly defines the single distal lumen.

6 . The catheter of claim 2 , wherein the distal subassembly includes a first outer diameter and the proximal subassembly includes a second outer diameter that is larger than the first outer diameter.

7 . The catheter of claim 1 , wherein the proximal subassembly coil includes a distal coiled portion having the first pitch, and a proximal coiled portion having a third pitch smaller than the first pitch.

8 . The catheter of claim 1 , wherein the distal subassembly coil includes a distal coiled portion having the second pitch, and a proximal coiled portion having a fourth pitch smaller than the second pitch.

9 . The catheter of claim 1 , wherein the plurality of first openings are spaced with a two coil pitch spacing of the proximal subassembly coil.

10 . A catheter comprising:

a proximal subassembly defining two proximal lumens, a proximal subassembly coil having a first pitch, and a plurality of first openings each extending through a wall of the proximal subassembly and disposed between adjacent coil windings of the proximal subassembly coil;

a distal subassembly defining a single distal lumen, a distal subassembly coil having a second pitch which is larger than the first pitch, and a plurality of second openings each extending through a wall of the distal subassembly and disposed between adjacent coil windings of the distal subassembly coil, wherein the plurality of second openings are arranged only in an alternating fashion on a top and a bottom portion of the catheter and each have a two coil pitch spacing; wherein the proximal subassembly coil is formed from a first wire; wherein the distal subassembly coil is formed from a second wire different from the first wire; wherein the distal subassembly coil is embedded in the wall of the distal subassembly, and wherein the first pitch is in a range from approximately 0.01 inches to approximately 0.03 inches.

11 . The catheter of claim 10 , wherein the plurality of first openings have a two coil pitch spacing of the proximal subassembly coil.

12 . A catheter comprising:

a proximal subassembly defining two proximal lumens, a proximal subassembly coil having a first pitch, and a plurality of first openings each extending through a wall of the proximal subassembly and disposed between adjacent coil windings of the proximal subassembly coil;

a distal subassembly defining a single distal lumen, a distal subassembly coil having a second pitch which is larger than the first pitch, and a plurality of second openings each extending through a wall of the distal subassembly and disposed between adjacent coil windings of the distal subassembly coil, wherein the plurality of second openings are arranged only in an alternating fashion on a top and a bottom portion of the catheter and each have a constant spacing;

wherein the proximal subassembly coil and the distal subassembly coil are separated from one another;

wherein the first pitch is in a range from approximately 0.01 inches to approximately 0.03 inches;

wherein the second pitch is in a range from approximately 0.06 inches to approximately 0.07 inches; and

wherein the distal subassembly coil is embedded in the wall of the distal subassembly.

13 . The catheter of claim 12 , wherein the plurality of first openings have a two coil pitch spacing of the proximal subassembly coil.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 29, 2025
From: MINNETRONIX NEURO, INC.
To: PHARAOH NEURO, INC.
Reel/Frame 073429/0607 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 2, 2025
From: MINNETRONIX, INC.
To: MINNETRONIX NEURO, INC.
Reel/Frame 071588/0980 →
PARTIAL RELEASE OF PATENT SECURITY AGREEMENT - REEL 054795 FRAME 0607; AND REEL 056240 FRAME 0147 Recorded Jun 10, 2025
From: TEXAS CAPITAL BANK, AS ADMINISTRATIVE AGENT
To: MINNETRONIX, INC.; MINNETRONIX NEURO, INC. (F/K/A NEUROFLUIDICS, INC.)
Reel/Frame 071588/0015 →
ASSIGNMENT OF SECURITY INTEREST IN PATENT COLLATERAL RECORDED ON REEL 054795 FRAME 0607 AND SUPPLEMENTAL PATENT SECURITY AGREEMENT RECORDED ON REEL 056240 FRAME 0147 Recorded Mar 13, 2025
From: FIRST HORIZON BANK
To: TEXAS CAPITAL BANK, AS SUCCESSOR AGENT
Reel/Frame 073460/0969 →
Continuity (3)
Continuation 14743652 · Jun 18, 2015
Provisional Application 62038998 · Aug 19, 2014
Related Publication 20210236782A1 · Aug 5, 2021
References Cited (387)
US 2969066A · Holter et al. · 1961 [cited by applicant]
US 3419010A · Williamson · 1968 [cited by applicant]
US 3867937A · Schwartz · 1975 [cited by applicant]
US 3889687A · Harris et al. · 1975 [cited by applicant]
US 4378797A · Osterholm · 1983 [cited by applicant]
US 4446154A · Osterholm · 1984 [cited by applicant]
US 4451251A · Osterholm · 1984 [cited by applicant]
US 4551137A · Osborne · 1985 [cited by applicant]
US 4686085A · Osterholm · 1987 [cited by applicant]
US 4767409A · Brooks · 1988 [cited by applicant]
US 4830849A · Osterholm · 1989 [cited by applicant]
US 4888115A · Marinaccio et al. · 1989 [cited by applicant]
US 4904237A · Janese · 1990 [cited by applicant]
US 4950232A · Ruzicka et al. · 1990 [cited by applicant]
US 4958901A · Coombs · 1990 [cited by applicant]
US 5160323A · Andrew · 1992 [cited by applicant]
US 5171226A · McCrory · 1992 [cited by applicant]
US 5190529A · McCrory et al. · 1993 [cited by applicant]
US 5334315A · Matkovich et al. · 1994 [cited by applicant]
US 5396899A · Strittmatter · 1995 [cited by applicant]
US 5405316A · Magram · 1995 [cited by applicant]
US 5423738A · Robinson et al. · 1995 [cited by applicant]
US 5462667A · Wollinsky et al. · 1995 [cited by applicant]
US 5531673A · Helenowski · 1996 [cited by applicant]
US 5601727A · Bormann et al. · 1997 [cited by applicant]
US 5658264A · Samson · 1997 [cited by examiner]
US 5683357A · Magram · 1997 [cited by applicant]
US 5755968A · Stone · 1998 [cited by applicant]
US 5772607A · Magram · 1998 [cited by applicant]
US 5836928A · Gerber et al. · 1998 [cited by applicant]
US 5897528A · Schultz · 1999 [cited by applicant]
US 5941853A · Collins · 1999 [cited by applicant]
US 5947689A · Schick · 1999 [cited by applicant]
US 5947940A · Beisel · 1999 [cited by examiner]
US 5948441A · Lenk et al. · 1999 [cited by applicant]
US 5980480A · Rubenstein et al. · 1999 [cited by applicant]
US 6013051A · Nelson · 2000 [cited by applicant]
US 6056725A · Elsberry · 2000 [cited by applicant]
US 6217552B1 · Barbut et al. · 2001 [cited by applicant]
US 6238382B1 · Schock et al. · 2001 [cited by applicant]
US 6264625B1 · Rubenstein et al. · 2001 [cited by applicant]
US 6326044B1 · Lindquist · 2001 [cited by applicant]
US 6379331B2 · Barbut et al. · 2002 [cited by applicant]
US 6383159B1 · Saul et al. · 2002 [cited by applicant]
US 6383380B1 · Kopf · 2002 [cited by applicant]
US 6387290B1 · Brody et al. · 2002 [cited by applicant]
US 6468219B1 · Njemanze · 2002 [cited by applicant]
US 6537241B1 · Odland · 2003 [cited by applicant]
US 6558353B2 · Zohmann · 2003 [cited by applicant]
US 6575928B2 · Saul et al. · 2003 [cited by applicant]
US 6594880B2 · Elsberry · 2003 [cited by applicant]
US 6616651B1 · Stevens · 2003 [cited by examiner]
US 6641563B1 · Vitullo et al. · 2003 [cited by applicant]
US 6682508B1 · Meythaler et al. · 2004 [cited by applicant]
US 6689085B1 · Rubenstein et al. · 2004 [cited by applicant]
US 6689756B2 · Hesson et al. · 2004 [cited by applicant]
US 6699269B2 · Khanna · 2004 [cited by applicant]
US 6709426B2 · Gijsbers et al. · 2004 [cited by applicant]
US 6758832B2 · Barbut et al. · 2004 [cited by applicant]
US 6830561B2 · Jansen et al. · 2004 [cited by applicant]
US 6849185B1 · Wu et al. · 2005 [cited by applicant]
US 6875192B1 · Saul et al. · 2005 [cited by applicant]
US 6969383B2 · Hildebrand · 2005 [cited by applicant]
US 7011647B2 · Purdy et al. · 2006 [cited by applicant]
US 7025742B2 · Rubenstein et al. · 2006 [cited by applicant]
US 7108680B2 · Rohr et al. · 2006 [cited by applicant]
US 7118549B2 · Chan · 2006 [cited by applicant]
US 7150737B2 · Purdy et al. · 2006 [cited by applicant]
US 7181289B2 · Pflueger et al. · 2007 [cited by applicant]
US 7189221B2 · Silverberg et al. · 2007 [cited by applicant]
US 7214211B2 · Woehr et al. · 2007 [cited by applicant]
US 7252659B2 · Shehada et al. · 2007 [cited by applicant]
US 7318834B2 · Njemanze · 2008 [cited by applicant]
US 7455666B2 · Purdy · 2008 [cited by applicant]
US 7708716B2 · Shah · 2010 [cited by applicant]
US 7787954B2 · Purdy · 2010 [cited by applicant]
US 7842002B2 · Mantle · 2010 [cited by applicant]
US 7850723B1 · Magers · 2010 [cited by applicant]
US 7887503B2 · Geiger · 2011 [cited by applicant]
US 8029495B2 · Pyles · 2011 [cited by applicant]
US 8131353B2 · Purdy · 2012 [cited by applicant]
US 8137334B2 · Heruth et al. · 2012 [cited by applicant]
US 8231586B2 · Kizer et al. · 2012 [cited by applicant]
US 8357296B2 · Bonhomme et al. · 2013 [cited by applicant]
US 8398581B2 · Panotopoulos · 2013 [cited by applicant]
US 8435204B2 · Lad et al. · 2013 [cited by applicant]
US 8444661B2 · Nair et al. · 2013 [cited by applicant]
US 8475419B2 · Eckermann · 2013 [cited by applicant]
US 8486023B2 · Pyles · 2013 [cited by applicant]
US 8486104B2 · Samson et al. · 2013 [cited by applicant]
US 8512280B2 · Rozenberg et al. · 2013 [cited by applicant]
US 8518636B2 · Bosch et al. · 2013 [cited by applicant]
US 8523930B2 · Saunders et al. · 2013 [cited by applicant]
US 8603057B2 · Hoffman et al. · 2013 [cited by applicant]
US 8669044B2 · Chiu et al. · 2014 [cited by applicant]
US 8679751B2 · Huang · 2014 [cited by applicant]
US 8721642B1 · Sullivan · 2014 [cited by applicant]
US 8905968B2 · Thomas · 2014 [cited by applicant]
US 9205184B2 · Eckermann · 2015 [cited by applicant]
US 9211163B1 · Jaramaz et al. · 2015 [cited by applicant]
US 9387311B1 · Heilman et al. · 2016 [cited by applicant]
US 10569064B2 · Vase et al. · 2020 [cited by applicant]
US 10632237B2 · Meyering et al. · 2020 [cited by applicant]
US 10695545B2 · Hedstrom et al. · 2020 [cited by applicant]
US 10850235B2 · Meyering et al. · 2020 [cited by applicant]
US 20020123714A1 · Saul et al. · 2002 [cited by applicant]
US 20020156482A1 · Scribner et al. · 2002 [cited by applicant]
US 20020193285A1 · Tesson et al. · 2002 [cited by applicant]
US 20030004495A1 · Saul · 2003 [cited by applicant]
US 20030014016A1 · Purdy · 2003 [cited by applicant]
US 20030028137A1 · Levin · 2003 [cited by applicant]
US 20030032915A1 · Saul · 2003 [cited by applicant]
US 20030065309A1 · Barnitz · 2003 [cited by applicant]
US 20030072761A1 · Lebowitz · 2003 [cited by applicant]
US 20030083698A1 · Whitehurst et al. · 2003 [cited by applicant]
US 20030097082A1 · Purdy et al. · 2003 [cited by applicant]
US 20030129134A1 · Chenard et al. · 2003 [cited by applicant]
US 20030130577A1 · Purdy et al. · 2003 [cited by applicant]
US 20030135196A1 · Hesson et al. · 2003 [cited by applicant]
US 20030163181A1 · Frazer et al. · 2003 [cited by applicant]
US 20030199802A1 · Barbut · 2003 [cited by applicant]
US 20040015133A1 · Karim · 2004 [cited by applicant]
US 20040030279A1 · Rubenstein et al. · 2004 [cited by applicant]
US 20040068221A1 · Silverberg et al. · 2004 [cited by applicant]
US 20040138125A1 · Wang · 2004 [cited by applicant]
US 20040138728A1 · Wong et al. · 2004 [cited by applicant]
US 20040142906A1 · Wang · 2004 [cited by applicant]
US 20040210231A1 · Boucher et al. · 2004 [cited by applicant]
US 20040215162A1 · Putz · 2004 [cited by applicant]
US 20040220545A1 · Heruth et al. · 2004 [cited by applicant]
US 20040254545A1 · Rider, II et al. · 2004 [cited by applicant]
US 20050004504A1 · Frye et al. · 2005 [cited by applicant]
US 20050060006A1 · Pflueger et al. · 2005 [cited by applicant]
US 20050090801A1 · Racz et al. · 2005 [cited by applicant]
US 20060015160A1 · Lamard · 2006 [cited by applicant]
US 20060030027A1 · Ellson et al. · 2006 [cited by applicant]
US 20060058836A1 · Bose et al. · 2006 [cited by applicant]
US 20060142783A1 · Lewis et al. · 2006 [cited by applicant]
US 20060175543A1 · Elefteriades · 2006 [cited by applicant]
US 20060184098A1 · Barnitz et al. · 2006 [cited by applicant]
US 20060224101A1 · Glenn · 2006 [cited by applicant]
US 20060282043A1 · Pyles · 2006 [cited by applicant]
US 20070050002A1 · Elefteriades · 2007 [cited by applicant]
US 20070246406A1 · Dibel et al. · 2007 [cited by applicant]
US 20070282303A1 · Nash et al. · 2007 [cited by applicant]
US 20080045883A1 · Radojicic · 2008 [cited by applicant]
US 20080154181A1 · Khanna · 2008 [cited by applicant]
US 20080171990A1 · Zauner · 2008 [cited by applicant]
US 20080208075A1 · Goldenberg · 2008 [cited by examiner]
US 20080249458A1 · Yamasaki · 2008 [cited by applicant]
US 20080249501A1 · Yamasaki · 2008 [cited by applicant]
US 20080319376A1 · Wilcox et al. · 2008 [cited by applicant]
US 20090076357A1 · Purdy · 2009 [cited by applicant]
US 20090082800A1 · Janardhan · 2009 [cited by applicant]
US 20090157044A1 · Liyanagama et al. · 2009 [cited by applicant]
US 20090171369A1 · Gayzik · 2009 [cited by applicant]
US 20090277850A1 · Adams et al. · 2009 [cited by applicant]
US 20100030196A1 · Hildebrand et al. · 2010 [cited by applicant]
US 20100145267A1 · Bishop et al. · 2010 [cited by applicant]
US 20100168665A1 · Skerven · 2010 [cited by applicant]
US 20100179509A1 · Pyles · 2010 [cited by applicant]
US 20100198195A1 · Nishtala et al. · 2010 [cited by applicant]
US 20100204672A1 · Lockhart et al. · 2010 [cited by applicant]
US 20100260815A1 · Kyle et al. · 2010 [cited by applicant]
US 20100280438A1 · Thomas · 2010 [cited by applicant]
US 20100305492A1 · Lad et al. · 2010 [cited by applicant]
US 20100324397A1 · Purdy · 2010 [cited by applicant]
US 20110029050A1 · Elefteriades et al. · 2011 [cited by applicant]
US 20110046547A1 · Mantle · 2011 [cited by applicant]
US 20110190831A1 · Mafi et al. · 2011 [cited by applicant]
US 20110264133A1 · Hanlon · 2011 [cited by examiner]
US 20110319824A1 · Pyles · 2011 [cited by applicant]
US 20120004625A1 · Velez-Rivera · 2012 [cited by applicant]
US 20120149021A1 · Yung et al. · 2012 [cited by applicant]
US 20120165757A1 · Purdy · 2012 [cited by applicant]
US 20120203142A1 · Bedell · 2012 [cited by applicant]
US 20120203290A1 · Warren et al. · 2012 [cited by applicant]
US 20120209367A1 · Prindle et al. · 2012 [cited by applicant]
US 20120253266A1 · Qureshi et al. · 2012 [cited by applicant]
US 20120302938A1 · Browd et al. · 2012 [cited by applicant]
US 20120330196A1 · Nita · 2012 [cited by applicant]
US 20130023814A1 · Bertrand et al. · 2013 [cited by applicant]
US 20130030411A1 · Kreck et al. · 2013 [cited by applicant]
US 20130035628A1 · Garrison et al. · 2013 [cited by applicant]
US 20130066331A1 · Chitre et al. · 2013 [cited by applicant]
US 20130085413A1 · Tsamir et al. · 2013 [cited by applicant]
US 20130131811A1 · Barreiro et al. · 2013 [cited by applicant]
US 20130158470A1 · Panotopoulos · 2013 [cited by applicant]
US 20130158564A1 · Harris et al. · 2013 [cited by applicant]
US 20130165903A1 · Webler et al. · 2013 [cited by applicant]
US 20130197422A1 · Browd et al. · 2013 [cited by applicant]
US 20130248450A1 · Kenley et al. · 2013 [cited by applicant]
US 20140066830A1 · Lad et al. · 2014 [cited by applicant]
US 20140166555A1 · Dibel et al. · 2014 [cited by applicant]
US 20140194840A1 · Eckermann · 2014 [cited by applicant]
US 20140276334A1 · Eckermann · 2014 [cited by applicant]
US 20140276660A1 · Eckermann · 2014 [cited by applicant]
US 20140316373A1 · Dhall · 2014 [cited by applicant]
US 20140323857A1 · Mourad et al. · 2014 [cited by applicant]
US 20150196742A1 · Browd et al. · 2015 [cited by applicant]
US 20150223832A1 · Swaney et al. · 2015 [cited by applicant]
US 20150224284A1 · Panotopoulos et al. · 2015 [cited by applicant]
US 20150238685A1 · Elias et al. · 2015 [cited by applicant]
US 20150257774A1 · Galdonik et al. · 2015 [cited by applicant]
US 20160051801A1 · Vase · 2016 [cited by applicant]
US 20160101270A1 · Browd et al. · 2016 [cited by applicant]
US 20160136398A1 · Heilman et al. · 2016 [cited by applicant]
US 20160174995A1 · Turjman et al. · 2016 [cited by applicant]
US 20160303355A1 · Heilman et al. · 2016 [cited by applicant]
US 20160303356A1 · Heilman et al. · 2016 [cited by applicant]
US 20170000361A1 · Meyering et al. · 2017 [cited by applicant]
CA 2407214A1 · 2003 [cited by applicant]
CA 2597293A1 · 2006 [cited by applicant]
CA 101288783A · 2008 [cited by applicant]
CA 2793672A1 · 2011 [cited by applicant]
CA 2936349A1 · 2015 [cited by applicant]
CN 101653637A · 2010 [cited by applicant]
CN 202409608U · 2012 [cited by applicant]
CN 102973305A · 2013 [cited by applicant]
CN 203816046U · 2014 [cited by applicant]
CN 203935243U · 2014 [cited by applicant]
CN 105361923A · 2016 [cited by applicant]
EP 0515007B1 · 1996 [cited by applicant]
EP 1331019A2 · 2003 [cited by applicant]
EP 2217315B1 · 2012 [cited by applicant]
EP 2695633A1 · 2014 [cited by applicant]
EP 2882483B1 · 2016 [cited by applicant]
GB 2365344A · 2002 [cited by applicant]
JP 03504681A · 1991 [cited by applicant]
JP 2001509712A · 2001 [cited by applicant]
JP 2001513349A · 2001 [cited by applicant]
JP 2002514096A · 2002 [cited by applicant]
JP 2003515394A · 2003 [cited by applicant]
JP 2003250881A · 2003 [cited by applicant]
JP 2003526398A · 2003 [cited by applicant]
JP 2004508109A · 2004 [cited by applicant]
JP 2004236792A · 2004 [cited by applicant]
JP 2004528062A · 2004 [cited by applicant]
JP 2006525827A · 2006 [cited by applicant]
RU 2100965C1 · 1998 [cited by applicant]
RU 2158613C2 · 2000 [cited by applicant]
RU 2290974C1 · 2007 [cited by applicant]
RU 2312678C1 · 2007 [cited by applicant]
RU 2314838C2 · 2008 [cited by applicant]
WO 8909629A1 · 1989 [cited by applicant]
WO 9205864A1 · 1992 [cited by applicant]
WO 9802202A1 · 1998 [cited by applicant]
WO 9833535A1 · 1998 [cited by applicant]
WO 9907276A2 · 1999 [cited by applicant]
WO 0041762A1 · 2000 [cited by applicant]
WO 0043056A1 · 2000 [cited by applicant]
WO 0051669A1 · 2000 [cited by applicant]
WO 0139819A2 · 2001 [cited by applicant]
WO 0211703A1 · 2002 [cited by applicant]
WO 0220083A2 · 2002 [cited by applicant]
WO 0232494A2 · 2002 [cited by applicant]
WO 03015710A2 · 2003 [cited by applicant]
WO 03020208A2 · 2003 [cited by applicant]
WO 03057306A1 · 2003 [cited by applicant]
WO 2004060463A1 · 2004 [cited by applicant]
WO 2004072647A1 · 2004 [cited by applicant]
WO 2004093945A1 · 2004 [cited by applicant]
WO 2004105839A1 · 2004 [cited by applicant]
WO 2005035025A1 · 2005 [cited by applicant]
WO 2005044335A2 · 2005 [cited by applicant]
WO 2005044847A1 · 2005 [cited by applicant]
WO 2006017763A1 · 2006 [cited by applicant]
WO 2006079007A2 · 2006 [cited by applicant]
WO 2006086195A1 · 2006 [cited by applicant]
WO 2007013945A2 · 2007 [cited by applicant]
WO 2007110643A1 · 2007 [cited by applicant]
WO 2008105959A2 · 2008 [cited by applicant]
WO 2009140202A1 · 2009 [cited by applicant]
WO 2009155614A2 · 2009 [cited by applicant]
WO 2010127071A1 · 2010 [cited by applicant]
WO 2010014447A3 · 2011 [cited by applicant]
WO 2011060317A2 · 2011 [cited by applicant]
WO 0154766A1 · 2011 [cited by applicant]
WO 2011114260A1 · 2011 [cited by applicant]
WO 2011150323A2 · 2011 [cited by applicant]
WO 2012099984A1 · 2012 [cited by applicant]
WO 2013034602A1 · 2013 [cited by applicant]
WO 2013052951A2 · 2013 [cited by applicant]
WO 2014023551A1 · 2014 [cited by applicant]
WO 2014023552A1 · 2014 [cited by applicant]
WO 2014039780A1 · 2014 [cited by applicant]
WO 2014160481A1 · 2014 [cited by applicant]
WO 2015104631A1 · 2015 [cited by applicant]
WO 2015109260A1 · 2015 [cited by applicant]
WO 2015157320A1 · 2015 [cited by applicant]
WO 2016007553A1 · 2016 [cited by applicant]
Elefteriades et al; Litigation in Nontraumatic Aortic Diseases—a Tempest in the Malpractice Maelstrom, Cardiology, vol. 109, pp. 263-272, 2008. [cited by applicant]
Enchev et al; “Historical Trends of Neuroendoscopic Surgical Techniques in the Treatment of Hydrocephalus,” Neurosurgery Review, vol. 31, pp. 249-262, 2008. [cited by applicant]
Gascoyne et al; “Dielectrophoretic Separation of Cancer Cells from Blood,” IEEE Transactions of Industry Applications, vol. 33, No. 3, pp. 670-678, May/Jun. 1997. [cited by applicant]
Gascoyne et al; “Isolation of Rare Cells from Cell Mixtures by Dielectrophoresis,” Electrophoresis, vol. 30. No. 8, pp. 1388-1398, Apr. 2009. [cited by applicant]
Gascoyne et al; “Particle Separation by Dielectrophoresis,” Electrophoresis, vol. 23, No. 13, pp. 1973-1983, Jul. 2002. [cited by applicant]
Haltiwanger, “The Electrical Properties of Cancer Cells”, www.royalrife.com/haltiwanger1, 62 pages, Jul. 2010. [cited by applicant]
Han et al; “An Electrorotation Technique for Measuring the Dielectric Properties of Cells with Simultaneous Use of Negative Quadropolar Dielectrophoresis and Electrorotation,” The Royal Society of Chemistry, vol. 138, p… [cited by applicant]
Helmy et al; “The Cytokine Response to Human Traumatic Brain Injury: Temporal Profiles and Evidence for Cerebral Parenchymal Production,” Journal of Cerebral Blood Flow & Metabolism, vol. 31, pp. 658-670, 2011. [cited by applicant]
Huang et al; “Electrode Design for Negative Dielectrophoresis,” Measurement Science and Technolgy, vol. 2, pp. 1142-1146, Dec. 1991. [cited by applicant]
Jones et al; “Multipolar Dielectrophoretic and Electrorotation Theory,” Journal of Electrostatics, vol. 37, pp. 121-134, 1996. [cited by applicant]
Lau et al; “Tau Protein Phosphorylation as a Therapeutic Target in Alzheimer's Disease,” Current Topics in Medicinal Chemistry, vol. 2, pp. 395-415, 2002. [cited by applicant]
Levi et al; “Clinical Application of Modest Hypothermia After Spinal Cord Injury,” J. Neurotrauma, vol. 26, No. 3, Abstract (1 page) pp. 407-415, Mar. 2009. [cited by applicant]
Li et al; “Continuous Dielectrophoretic Cell Separation Microfluidic Device,” The Royal Society of Chemistry, Lab Chip, vol. 7, pp. 239-248, 2007. [cited by applicant]
Madeira-Lopes et al; Comparative Study of the Temperature Profiles of Growth and Death of the Pathogenic Yeast Cryptococcus Neoformans and the non-pathogenic Cryptococcus Albidus, Journal of Basic Microbiology, vol. 26,… [cited by applicant]
Markx et al; “Dielectrophoretic Separation of Bacteria Using a Conductivity Gradient,” Journal of Biotechnology, vol. 51, pp. 175-180, Dec. 1996. [cited by applicant]
Markx et al; “Dielectrophoretic Separation of Cells: Continuous Separation,” Biotechnology and Bioengineering, vol. 45, No. 4, pp. 337-343, Feb. 1995. [cited by applicant]
Marszalek et al; “Determination of Electrical Parameters of Cell Membranes by a Dielectrophoresis Method,” Biophysical Journal, vol. 59, pp. 982-987, May 1991. [cited by applicant]
McKeating et al; “Cytokines and Adhesion Molecules in Acute Brain Injury,” British Journal of Anaesthesia, vol. 80, pp. 77-84, 1998. [cited by applicant]
Misaki et al; “Contrast-Enhanced Fluid-Attenuated Inversion Recovery MRI is useful to Detect the CSF Dissemination of Glioblastoma,” Journal of Computer Assisted Tomography, vol. 25, No. 6, pp. 953-956, 2001. [cited by applicant]
Morganti-Kossman et al; “Production of Cytokines Following Brain Injury: Beneficial and Deleterious for the Damaged Tissue,” Molecular Psychiatry, vol. 2, pp. 133-136, 1997. [cited by applicant]
Onda et al; “Cerebral Glioblastoma with Cerebrospinal Fluid Dissemination: a Clinicopathological Study of 14 Cases Examined by Complete Autopsy,” Neurosurgery, vol. 25, No. 4, pp. 533-540, 1989. [cited by applicant]
Park et al; “3-D Electrode Designs for Flow-Through Dielectrophoretic Systems,” Electrophoresis, vol. 26, pp. 3745-3757, 2005. [cited by applicant]
Park “Continuous Dielectrophoretic Bacterial Separation and Concentration from Physiological Media of High Conductivity” The Royal Society of Chemistry, Lab Chip, vol. 11, pp. 2893-2900, 2011. [cited by applicant]
Perfect, “Cryptococcus Neoformans: the Yeast that Likes it Hot,” FEMS Yeast Res; vol. 6, pp. 463-468, 2006. [cited by applicant]
Pethig et al; “Applicants of Dielectrophoresis in Biotechnology,” Tibtech, vol. 15, pp. 426-432, Oct. 1997. [cited by applicant]
Pethig, “Dielectrophoresis: Status of the Theory, Technology, and Applications,” Biomicrofluidics, vol. 4, pp. 022811-1-02281-35, 2010. [cited by applicant]
Pethig, “Dielectrophoresis: Using Inhomogeneous AC Electrical Fields to Separate and Manipulate Cells,” Critical Reviews in Biotechnology, vol. 16, No. 4, pp. 331-348, 1996. [cited by applicant]
Polderman et al; “Therapeutic Hypothermia and Controlled Normothermia in the Intensive Care Unit: Practical Considerations, Side Effects, and Cooling Methods,” Crit. Care Med; vol. 37, No. 3, Abstract (1 page), Mar. 200… [cited by applicant]
Reiber, “Proteins in cerebrospinal fluid and blood: Barriers, CSF flow rate and source-related dynamics”, Restorative Neurology and Neuroscience, vol. 21, pp. 79-96, 2003. [cited by applicant]
Stephens et al; “The Dielectrophoresis Enrichment of CD34 Cells from Peripheral Blood Stem Cell Harvests,” vol. 18, pp. 777-782, 1996. [cited by applicant]
Tay et al; “Electrical and Thermal Characterization of a Dielectrophoretic Chip with 3D Electrodes for Cells Manipulation,” Electrochimica. Acta; vol. 52, pp. 2862-2868, 2007. [cited by applicant]
Author Unknown, “External CSF Drainage,” Aqueduct Neurosciences, (2 pages), Jul. 2014. [cited by applicant]
Author Unknown, “Therapeutic Hypothermia for Spinal Cord Injury,” Crit. Care Med. vol. 37, Supp. 7, Abstract (1 page), Jul. 2009. [cited by applicant]
Author Unknown, “LiquoGuard”, Moller Medical, Brochure, 2 pages, published on or before 2015. [cited by applicant]
Author Unknown, World Journal of Radiology, vol. 4, No. 6, pp. 241-290, Jun. 28, 2012. [cited by applicant]
Voldman, “Electrical Forces for Microscale Cell Manipulation,” Annu. Rev. Biomed. Eng; vol. 8, pp. 425-454, 2006. [cited by applicant]
Weis et al; “Noninvasive Monitoring of Brain Temperature During Mild Hypothermia,” vol. 27, No. 7, Abstract (1 page), Sep. 2009. [cited by applicant]
Ziebell et al; Involvement of Pro- and Anti-Inflammatory Cytkines and Chemokines in the Pathophysiology of Traumatic Brain Injury, Neurotherapeutics: the Journal of the American Society for Experimental NeuroTherapeutic… [cited by applicant]
European Office Action for European Patent Application No. 07873762.4, dated Dec. 7, 2016 (5 pages). [cited by applicant]
Mahon et al; North American Clinical Experience with the EKOS MicroLysUS Infusion Catheter for the Treatment of Embolic Stroke, AJNR Am J. Neuroradiology, vol. 24, pp. 534-538, Mar. 2003. [cited by applicant]
Rogers et al; “Percutaneous aspiration of brain tumor cysts via the Ommaya reservoir system,” Neurology, vol. 41, pp. 279-282, Feb. 1991. [cited by applicant]
Siddiqui et al; “Use of the Penumbra System 054 plus Low Dose Thrombolytic Infusion for Multifocal Venous Sinus Thrombosis,” Interventional Neuroradilogy, vol. 18, pp. 314-319, 2012. [cited by applicant]
Spiegelberg GmbH & Co. KG, “EVD-Catheters,” downloaded on Nov. 3, 2016 from website, http://www.spiegelberg.de/products/drainage/silverline_evd_catheter_3001002.html (1 page). [cited by applicant]
Wagner et al; “Ultra-early clot aspiration after lysis with tissue plasminogen activator in a porcine model of intracerebral hemororrhage: edema reduction and blood-brain barrier protection,” J. Neurosurg; vol. 90, pp. … [cited by applicant]
Ziu et al; “A Series of Cerebral Venous Sinus Thromboses Treated with Intra-Arterial tPA infused over Ten Hours with a 0.027-inch Catheter and Literature Review,” pp. 1-13, Jun. 23, 2016. [cited by applicant]
International Search Report and Written Opinion for International Application PCT/US2016/036626, mailed Sep. 3, 2016 (12 pages). [cited by applicant]
European Search Report and Opinion for European Patent Application No. 07873762.4 dated May 27, 2011 (11 pages). [cited by applicant]
International Search Report and Written Opinion of the International Searching Authority for International Patent Application No. PCT/US2010/01186, mailed Jun. 21, 2010 (7 pages). [cited by applicant]
International Search Report and Written Opinion of the International Searching Authority for International Patent Application No. PCT/US2007/80834, mailed Oct. 28, 2008 (8 pages). [cited by applicant]
Banci, et al; “Metal-free superoxide dismutase forms soluble oligomers under physiological conditions: a possible general mechanism for familial ALS,” PNAS, vol. 104, No. 27, pp. 11263-11267, Jul. 3, 2007. [cited by applicant]
Bayer et al; “Evaluation of the safety and immunogenicity of synthetic AB42 (AN1792) in patients with AD,” Neurology, vol. 64, pp. 94-101, Jan. 2005. [cited by applicant]
Blennow et al; “Alzheimer's disease,” Lancet, vol. 368, pp. 387-403, Jul. 29, 2006. [cited by applicant]
Caughey et al, “Protofibrils, pores, fibrils and neurodegeneration: separating the responsible aggregates from the innocent bystanders,” Annu. Rev. Neurosci. vol. 26, pp. 267-298, 2003. [cited by applicant]
Dawson et al; “Molecular Pathways of Neurodegeneration in Parkinson's Disease,” Science, vol. 302, pp. 819-822, Oct. 21, 2003. [cited by applicant]
Dekosky et al; “Looking Backward to Move Forward: Early Detection of Neurodegenerative Disorders,” Science, pp. 830-834, Oct. 31, 2003. [cited by applicant]
Dias-Santagata et al; “Oxidative stress mediates tau-induced neurodegeneration in [cited by applicant]
Dunnett et al; “Prospects for new restorative and neuroprotective treatments in Parkinson's disease”, Nature, vol. 399, pp. A32-A38, SUPP, Jun. 24, 1999. [cited by applicant]
Gilman et al; “Clinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trial,” Neurology, vol. 64, pp. 1553-1562, May 2005. [cited by applicant]
Glabe, “Common mechanisms of amyloid oligomer pathogenesis in degenerative disease,” Neurobiology of Aging, vol. 27, pp. 570-575, 2006. [cited by applicant]
Hansson et al; “Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study,” Lancet Neurol; vol. 5, pp. 228-234, Mar. 2006. [cited by applicant]
Hock et al; “Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease,” Neuron, vol. 38, pp. 547-554, May 22, 2003. [cited by applicant]
Hohlfeld et al; “Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: From pipe dreams to (therapeutic) pipelines,” PNAS, vol. 101, Suppl. 2, pp. 14599-14606, Oct. 5, 2004. [cited by applicant]
Janus et al; “A beta peptide immunization reduces behavioral impairment and plaques in a model of Alzheimer's disease,” Nature, vol. 408, pp. 979-982, Dec. 2000. [cited by applicant]
Kessler et al; “Endothelin- 1 levels in plasma and cerebrospinal fluid of patients with cerebral vasospasm after aneurysmal subarachnoid hemorrhage,” Surgical Neurology, vol. 64, pp. S1:2-S1:5, 2005. [cited by applicant]
Koo et al; “Amyloid diseases: Abnormal protein aggregation in neurodegeneration,” Proc. Natl. Acad. Sci; vol. 96, pp. 9989-9990, Aug. 1999. [cited by applicant]
Kuwabara et al; “Intravenous immunoglobin therapy for Guillan-Barre syndrome with IgG anti-GM1 antibody,” Muscle & Nerve, pp. 53-58, Jan. 2001. [cited by applicant]
MacDonald et al; “Cerebral vasospasm after subarachnoid hemorrage: the emerging revolution,” Nature Clinical Practice, Neurology, vol. 3, No. 5, pp. 256-263, May 2007. [cited by applicant]
Mascia et al; “Temporal Relationship Between Endothelin-1 Concentrations and Cerebral Vasospasm in Patients With Aneurysmal Subarachnoid Hemorrhage-Editorial Comment: Endothelin-1 in Vasospasm After SAH,” Stroke, pp. 11… [cited by applicant]
McCulloch et al; “A radical approach to stroke therapy,” PNAS, vol. 98, No. 20, pp. 10989-10991, Sep. 25, 2001. [cited by applicant]
McKhann et al; “Plasmapherisis and Guillain-Barre syndrome: analysis of prognostic factors and the effect of plasmapheresis,” Annals of Neurology, vol. 23, No. 4, pp. 347-353, Apr. 1988. [cited by applicant]
Melnikova, “Therapies for Alzheimer's disease,” Nature Reviews, vol. 6, pp. 341-342, May 2007. [cited by applicant]
Monsonego et al; “Immunotherapeutic Approaches to Alzheimer's Disease”, Science, vol. 302,pp. 834-838, Oct. 31, 2003. [cited by applicant]
Morgan et al; “A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease,” Nature, vol. 408, pp. 982-985, Dec. 2000. [cited by applicant]
Nicoll et al; “Abeta species removal after abeta42 immunization,” Journal of Neuropathology Exp. Neurol; vol. 65, No. 11, pp. 1040-1048, Nov. 2006. [cited by applicant]
Noseworthy, “Progress in determining the causes and treatment of multiple sclerosis,” Nature, vol. 399, Supp., pp. A40-A47, Jun. 24, 1999. [cited by applicant]
Orogozo et al; “Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization,” Neurology, vol. 61, pp. 46-54, Jul. 2003. [cited by applicant]
Parkhill et al; “The genome sequence of the food-borne pathogen [cited by applicant]
Roberson et al; “100 Years and Counting: Prospects for Defeating Alzheimer's Disease,” Science, vol. 314, pp. 781-784, Nov. 3, 2006. [cited by applicant]
Rowland, “Amyotrophic Lateral Sclerosis: Human Challenge for Neuroscience,” Proc. Natl. Acad. Sci; vol. 92, pp. 1251-1253, Feb. 1995. [cited by applicant]
Shoulson, “Experimental Therapeutics of Neurodegenerative Disorders: Unmet Needs,” Science, vol. 282, pp. 1072-1074, Nov. 6, 1998. [cited by applicant]
Steece-Collier et al; “Etiology of Parkinson's disease: Genetics and environment revisited,” PNAS, vol. 99, No. 22, pp. 13972-13974, Oct. 29, 2002. [cited by applicant]
Taylor et al; “Toxic Proteins in Neurodegenerative Disease,” Science, vol. 296, pp. 1991-1995, Jun. 14, 2002. [cited by applicant]
Valentine et al; “Misfolded CuZnSOD and amyotrophic lateral sclerosis,” PNAS, vol. 100, No. 7, pp. 3617-3622, Apr. 1, 2003. [cited by applicant]
Vernino et al; “Autoimmune encephalopathies,” The Neurologist, vol. 13, No. 3, May 2007. [cited by applicant]
Wollinsky et al; CSF filtration is an effective treatment of Guillan-Barre syndrome: a randomized clinical trial, Neurology, vol. 57, pp. 774-780, Sep. 2001. [cited by applicant]
Yuki et al; “Carbohydrate mimicry between human ganglioside GM1 and Campylobacter Jejuni lipooligosaccaride causes Guillain-Barre syndrome,” PNAS, vol. 101, No. 31, pp. 11404-11409, Aug. 3, 2004. [cited by applicant]
Japanese Rejection of Appeal for related Japanese Patent Application No. 2009-531646, mailed Jan. 25, 2016 (13 pages). [cited by applicant]
Arnold et al; “Electro-Rotation: Development of a Technique for Dielectric Measurements on Individual Cells and Particles.” Journal of Electrostatics, vol. 21, pp. 151-191, 1988. [cited by applicant]
Arvin et al; “The Role of Inflammation and Cytokines in Brain Injury,” Neuroscience and Biobehavorial Reviews, vol. 20, No. 3, pp. 445-452, 1996. [cited by applicant]
Becker et al; “Separation of Human Breast Cancer Cells from Blood by Differential Dielectric Affinity,” Proc. Natl. Acad. Sci, vol. 92, pp. 860-864, Jan. 1995. [cited by applicant]
Becker et al; “The Removal of Human Leukemia Cells for Blood Using Interdigitated Microelectrodes,” J. Phys. D: Appl. Phys; vol. 27, pp. 2659-2662, 1994. [cited by applicant]
Buzzigoli et al; “Plasmapherisis treatment in Guillain-Barre syndrome: potential benefit over intravenous immunoglobin,” Anaesth Intensive Care, vol. 38, No. 2, pp. 387-389, Abstract (1 page) Mar. 2010. [cited by applicant]
Cambria et al; “Clinical Experience with Epidural Cooling for Spinal Cord Protection during Thoracic and Thoracoaabdominal Aneurysim Repair,” Journal of Vascular Surgery, vol. 25, No. 2, pp. 234-243, Feb. 1997. [cited by applicant]
Cook, “Combined Spinal-Epidural Techniques,” Anaesthesia, vol. 55, pp. 42-64, 2000. [cited by applicant]
Covaciu et al; “Brain Temperature in Volunteers Subjected to Intranasal Cooling,” Intensive Care Med; vol. 37, No. 8, Abstract (1 page) 1277-1284, Aug. 2011. [cited by applicant]
Delhaas, “Extradural and Subarachnoid Catheterization Using the Seldinger Technique,” British Journal of Anaesthesia, vol. 76, pp. 149-150, 1996. [cited by applicant]